Fraction of exhaled nitric oxide as a predictor in juvenile idiopathic arthritis progression

In this study, the relation between the nitric oxide (NO) levels in the serum and fraction of exhaled nitric oxide (F E NO) in children with juvenile idiopathic arthritis (JIA) and the activation criteria of the disease has been investigated. The study group consisted of 35 JIA-diagnosed patients an...

Full description

Saved in:
Bibliographic Details
Published in:Clinical rheumatology 2017-03, Vol.36 (3), p.541-546
Main Authors: Doğruel, Dilek, Yılmaz, Mustafa, Bingöl, Gülbin, Altıntaş, Derya Ufuk, Güneşer Kendirli, Seval
Format: Article
Language:English
Subjects:
Adolescent
Arthritis, Juvenile - blood
Arthritis, Juvenile - diagnosis
Breath Tests
Child
Child, Preschool
Disease Progression
Exhalation
Female
Humans
Male
Medicine
Medicine & Public Health
Nitric Oxide - analysis
Original Article
Prognosis
Rheumatology
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this study, the relation between the nitric oxide (NO) levels in the serum and fraction of exhaled nitric oxide (F E NO) in children with juvenile idiopathic arthritis (JIA) and the activation criteria of the disease has been investigated. The study group consisted of 35 JIA-diagnosed patients and 18 healthy children. According to the clinical and laboratory findings, the patients with JIA were divided into two groups, active (group I) and in remission (group II). The healthy children were classified as group III. The activation criteria of the disease were determined for each patient. The serum NO level and F E NO level were measured in all the patients. In the group with JIA, correlation was detected between F E NO level and number of involved joints and number of joints with limited motion. In addition, correlation was determined between the F E NO level and number of involved joints in group I and the serum NO level and activity score in group II. However, it was seen that there is no statistical difference in the serum NO level and F E NO level of the patients with JIA and the control group and groups I and II. This study demonstrated the correlation between F E NO level and number of involved joints and number of joints with limited motion in patients with JIA. Our results matter in terms of F E NO being a noninvasive laboratory marker in following the progression of the disease.
ISSN:0770-3198
1434-9949
DOI:10.1007/s10067-016-3371-1